COVID-19 is an emerging, rapidly evolving situation.
NIH Global Health Funding News - Week of October 22, 2018
On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding
opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates
are typically distributed once a week.
NIH funding opportunities focusing on global health and foreign collaboration.
International Summit in Human Genetics and Genomics, sponsored by the National Human Genome Research Institute (NHGRI), other Institutes and Centers at NIH, and the Foundation for the NIH, will train early-mid career stage health care professionals and trainees from developing nations. Research scientists, physicians, dentists, dentist-scientists, nurses, counselors and medical, dental and graduate school trainees can apply. Selected candidates will be fully sponsored (travel, local transportation, lodging, per diem) for the duration of the Summit, August 28 - September 28, 2019. Selections are on a rolling basis and seats are limited so please apply early.
Application deadline: December 10, 2018
NIH Loan Repayment Program (LRP) applications for extramural awards are due November 15, 2018. Fogarty can be listed as a secondary institution on applications.
NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.
NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.
NIH funding news that may be relevant to global health researchers.
- Responsibilities of Recipient Institutions in Communicating Research Misconduct to the NIH (NOT-OD-19-020)
- Request for Information (RFI) on the Proposed Funding Priorities for Neuroscience Research, Input on Cross-Cutting Opportunities (NIH Neuroscience Blueprint) (NOT-NS-19-002)
- Notice of Availability of Administrative Supplements for Microphysiological Systems Developers : Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose (NOT-TR-19-001)